review Open AccessTop 1% cited
Economic impact of medication non-adherence by disease groups: a systematic review
BMJ Open · 2018 · Vol. 8(1) · pp. e016982–e016982
Rachelle Louise Cutler✉(University of Technology Sydney)Fernando Fernández-Llimós(University of Lisbon)Michael Frommer(The University of Sydney)Charlie S Benrimoj(University of Technology Sydney)Victoria García‐Cárdenas(University of Technology Sydney)
Abstract
CRD42015027338.
Medication Adherence and CompliancePharmaceutical studies and practicesPharmaceutical Economics and PolicyMedicineChecklistPharmacyHealth careScopusHealth economicsMEDLINEDiseaseFamily medicineEnvironmental health
MeSH terms
Assessment of Medication AdherenceCost-Benefit AnalysisDiseaseDrug TherapyHumansDrug MonitoringCost of IllnessMedication Adherence
Funding
- Australian Government
Citations
874
FWCI
63.22
field-weighted impact
References
114
Percentile
100%
vs. same field & year
Citations per year
References
Interventions for helping patients to follow prescriptions for medications
Cochrane Database of Systematic Reviews · 2002 · 908 citations
Guidelines for authors and peer reviewers of economic submissions to the BMJ
BMJ · 1996 · 1,825 citations
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Annals of Internal Medicine · 2009 · 37,606 citations
Impact of Medication Adherence on Hospitalization Risk and Healthcare Cost
Medical Care · 2005 · 1,741 citations
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
BMJ · 2009 · 82,871 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.